Stay updated on Cisplatin, Romidepsin & Nivolumab in TNBC Clinical Trial
Sign up to get notified when there's something new on the Cisplatin, Romidepsin & Nivolumab in TNBC Clinical Trial page.

Latest updates to the Cisplatin, Romidepsin & Nivolumab in TNBC Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check10 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check46 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new identifiers and collaborators related to a study on Triple-Negative Breast Cancer, while extensive details about the study's phases, criteria, and background information have been removed.SummaryDifference46%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Cisplatin, Romidepsin & Nivolumab in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cisplatin, Romidepsin & Nivolumab in TNBC Clinical Trial page.